Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Larry J Copeland
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
315 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Tennessee Valley Gynecologic Oncology
Huntsville, Alabama, United States
- Saint Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Highlands Oncology Group Pa - Fayetteville
Fayetteville, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Long Beach Memorial Medical Center-Todd Cancer Institute
Long Beach, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- University of California San Diego
San Diego, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- University of Colorado Hospital
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- Scl Health Saint Joseph Hospital
Denver, Colorado, United States
- Western States Cancer Research Ncorp
Denver, Colorado, United States
- Rocky Mountain Gynecologic Oncology Pc
Englewood, Colorado, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Saint Mary'S Hospital and Regional Medical Center
Grand Junction, Colorado, United States
- North Colorado Medical Center
Greeley, Colorado, United States
- Littleton Adventist Hospital
Littleton, Colorado, United States
- Mckee Medical Center
Loveland, Colorado, United States
- Parker Adventist Hospital
Parker, Colorado, United States
- Scl Health Lutheran Medical Center
Wheat Ridge, Colorado, United States
- University of Connecticut
Farmington, Connecticut, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Eastern Connecticut Hematology and Oncology Associates
Norwich, Connecticut, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Mar 2005
- Primary completion
- 3 Feb 2015
- Completion
- 22 Feb 2022
- Last update posted
- 30 Sept 2021
- Registered enrollment
- 1,157
- Registry id
- NCT00108745
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.